Value of Urinary Neutrophil Gelatinase-Associated Lipocalin in Diagnosing Urinary Tract Infections in Children: A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.52547/z3ptqh88Keywords:
Neutrophil gelatinase-associated lipocalin, Urinary tract infection, Acute pyelonephritis, Meta-analysisAbstract
This study presents a comprehensive review of the literature regarding the use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) as a diagnostic tool for urinary tract infection (UTI) in children. Meta-analysis was conducted to evaluate the effectiveness of uNGAL in diagnosing UTI and differentiating acute pyelonephritis (APN) from other sites infection in pediatric patients. We searched PubMed, Web of Science, the Cochrane Library and EMBASE for reports published up to January 2023. We only included published literature that addressed the diagnosis of UTI and APN with the use of uNGAL in children aged 0-18 years. Two authors independently reviewed the included studies and extracted the corresponding data according to the inclusion and exclusion criteria. The sensitivity, specificity and area under the curve for each study were pooled by using a bivariate mixed-effects model. A total of 13 studies met the inclusion criteria for this review: 8 reported on uNGAL diagnosis of UTI, 2 on uNGAL diagnosis of APN, and 3 on both UTI and APN. Among all included studies, uNGAL had good sensitivity (0.88, 95% CI 0.79-0.94) and good specificity (0.86, 95% CI 0.78-0.92) for the diagnosis of UTI. The sensitivity and specificity of uNGAL for the diagnosis of APN were 0.79 (95% CI 0.72-0.85) and 0.78 (95% CI 0.50-0.93), respectively. uNGAL has good sensitivity and specificity in the diagnosis of UTI in children and is a promising marker. However, the use of uNGAL still does not provide significant advantages in the diagnosis of APN in children. Consequently, there is a need to optimize and further explore the assay for improved diagnostic accuracy.
Downloads
References
1. Chaudhari PP, Monuteaux MC, Bachur RG. Urine Concentration and Pyuria for Identifying UTI in Infants. Pediatrics. 2016,138(5).
2. Becknell B, Schober M, Korbel L, Spencer JD. The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti Infect Ther. 2015,13(1):81-90.
3. Das R, Ahmed T, Saha H, et al. Clinical risk factors, bacterial aetiology, and outcome of urinary tract infection in children hospitalized with diarrhoea in Bangladesh. 2017,145(5):1018-1024.
4. Kjeldsen L, Bainton DF, Sengeløv H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994,83(3):799-807.
5. Paragas N, Kulkarni R, Werth M, et al. α-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest. 2014,124(7):2963-2976.
6. Shemin D, Dworkin LD. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury. Crit Care Clin. 2011,27(2):379-389.
7. Valdimarsson S, Jodal U, Barregård L, Hansson S. Urine neutrophil gelatinase-associated lipocalin and other biomarkers in infants with urinary tract infection and in febrile controls. Pediatr Nephrol. 2017,32(11):2079-2087.
8. Moon JH, Yoo KH, Yim HE. Urinary neutrophil gelatinase-associated lipocalin: a marker of urinary tract infection among febrile children. Clin Exp Pediatr. 2021,64(7):347-354.
9. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj. 2009,339:b2700.
10. Yang SS, Tsai JD, Kanematsu A, Han CH. Asian guidelines for urinary tract infection in children. J Infect Chemother. 2021,27(11):1543-1554.
11. Stokland E, Hellström M, Jacobsson B, et al. Early 99mTc dimercaptosuccinic acid (DMSA) scintigraphy
in symptomatic first-time urinary tract infection. Acta Paediatr. 1996,85(4):430-436.
12. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011,155(8):529-536.
13. Van Houwelingen HC, Zwinderman KH, Stijnen T.
A bivariate approach to meta-analysis. Stat Med. 1993,12(24):2273-2284.
14. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002,21(4):589-624.
15. Riley RD, Abrams KR, Sutton AJ, Lambert PC, Thompson JR. Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol. 2007,7:3.
16. Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005,58(10):982-990.
17. B D. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Statistical Software Components. 2019, 14(Feb).
18. Deeks JJ, Macaskill P, Irwig L. The performance of
tests of publication bias and other sample size effects
in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005,58(9):882-893.
19. Jagadesan I, Agarwal I, Chaturvedi S, et al. Urinary Neutrophil Gelatinase Associated Lipocalin - A Sensitive Marker for Urinary Tract Infection in Children. Indian J Nephrol. 2019,29(5):340-344.
20. Jung N, Byun HJ, Park JH, et al. Diagnostic accuracy of urinary biomarkers in infants younger than 3 months with urinary tract infection. Korean J Pediatr. 2018,61(1):24-29.
21. Osama Y Safdar; Mohammed A Shalaby; Wael M Toffaha; Alanoud A Turki; Waleed M Toffaha AHGSMNAMAAKB. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker for the Diagnosis of Urinary Tract Infections in Saudi Children. Journal of Nephrology & Therapeutics. 2015,2015(06).
22. Lubell TR, Barasch JM, Xu K, et al. Urinary Neutrophil Gelatinase-Associated Lipocalin for the Diagnosis of Urinary Tract Infections. Pediatrics. 2017,140(6).
23. Yilmaz A, Sevketoglu E, Gedikbasi A, et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol. 2009,24(12):2387-2392.
24. Krzemień G, Pańczyk-Tomaszewska M, Adamczuk D,
et al. Neutrophil Gelatinase-Associated Lipocalin: A Biomarker for Early Diagnosis of Urinary Tract Infections in Infants. Adv Exp Med Biol. 2018,1047:71-80.
25. S haikh N, Liu H, Kurs-Lasky M, Forster CS. Biomarkers for febrile urinary tract infection in children. Pediatr Nephrol. 2022,37(1):171-177.
26. Y im HE, Yim H, Bae ES, Woo SU, Yoo KH. Predictive value of urinary and serum biomarkers in young children with febrile urinary tract infections. Pediatr Nephrol. 2014,29(11):2181-2189.
27. G hasemi K, Esteghamati M, Borzoo S, Parvaneh E, Borzoo S. Predictive Accuracy of Urinary neutrophil gelatinase associated lipocalin (NGAL) for renal parenchymal involvement in Children with Acute Pyelonephritis. Electron Physician. 2016,8(2):1911-1917.
28. N ickavar A, Safaeian B, Valavi E. Validity of Neutrophil Gelatinase Associated Lipocaline as a Biomarker
for Diagnosis of Children with Acute Pyelonephritis. 2016,13(5):2860-2863.
29. A rambašić J, Mandić S, Debeljak Ž, et al. Differentiation of acute pyelonephritis from other febrile states in children using urinary neutrophil gelatinase-associated lipocalin
(uNGAL). Clin Chem Lab Med. 2016,54(1):55-61.
30. Zou Z, Chen B, Tang F, Li X, Xiao D. Predictive value
of neutrophil gelatinase-associated lipocalin in children with acute kidney injury: A systematic review and meta-analysis. Front Pediatr. 2023,11:1147033.
31. Lee HE, Kim DK, Kang HK, Park K. The diagnosis of febrile urinary tract infection in children may be facilitated by urinary biomarkers. Pediatr Nephrol. 2015,30(1):123-130.
32. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates
an innate immune response to bacterial infection by sequestrating iron. Nature. 2004,432(7019):917-921.
33. Borrega ard N, Cowland JB. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals. 2006,19(2):211-215.
34. Goetz D H, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002,10(5):1033-1043.
35. Yamanou chi S, Kimata T, Akagawa Y, et al. Reduced urinary excretion of neutrophil gelatinase-associated lipocalin as a risk factor for recurrence of febrile urinary tract infection in children. 2021,36(6):1473-1479.
36. Lubell TR, Barasch JM, King B, et al. Urinary tract infections in children: Testing a novel, noninvasive, point-of-care diagnostic marker. Acad Emerg Med. 2022,29(3):326-333.
37. Majd M, Rushton HG. Renal cortical scintigraphy in the diagnosis of acute pyelonephritis. Semin Nucl Med. 1992,22(2):98-111.
38. Cai L, Rubin J, Han W, Venge P, Xu S. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol. 2010,5(12):2229-2235.
39. Kjeldse n L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993,268(14):10425-10432.
40. Xu SY, C arlson M, Engström A, et al. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest. 1994,54(5):365-376.
41. Hatipoglu S, Sevketoglu E, Gedikbasi A, et al. Urinary MMP-9/NGAL complex in children with acute cystitis. Pediatr Nephrol. 2011,26(8):1263-1268.
42. Zhou H, C ui J, Lu Y, Sun J, Liu J. Meta-analysis of the diagnostic value of serum, plasma and urine neutrophil gelatinase-associated lipocalin for the detection of acute kidney injury in patients with sepsis. Exp Ther Med. 2021,21(4):386.
43. Wetterste n N, Horiuchi Y, van Veldhuisen DJ, et al. Short-term prognostic implications of serum and urine neutrophil gelatinase-associated lipocalin in acute heart failure: findings from the AKINESIS study. Eur J Heart Fail. 2020,22(2):251-263.
44. Shaikh K, Rajakumar V, Osio VA, Shaikh N. Neutrophil gelatinase-associated lipocalin for urinary tract infection and pyelonephritis: a systematic review. 2021,36(6):1481-1487.
